Our results demonstrate the diagnostic capacity of lncRNA methylation in AD blood, providing novel insights into the development of noninvasive biomarkers of AD.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: